AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release

EMBO Journal

Volumn 29, Issue 16, 2010, Pages 2813-2826

  Bendor, Jacob ^a   Lizardi Ortiz, José E ^b   Westphalen, Robert I ^c   Brandstetter, Markus ^a   Hemmings, Hugh C ^c   Sulzer, David ^b   Flajolet, Marc ^a   Greengard, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

AGAP1; AP 3; dopamine; endocytic recycling; muscarinic receptors

Indexed keywords

ADAPTOR PROTEIN; AGAP1 PROTEIN; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; MUSCARINIC M5 RECEPTOR; PROTEIN; UNCLASSIFIED DRUG; AGAP1 PROTEIN, MOUSE; AGAP1 PROTEIN, RAT; DOPAMINE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN;

ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; HOMEOSTASIS; IN VIVO STUDY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RAT; RECEPTOR DOWN REGULATION; STIMULATION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENDOCYTOSIS; FEMALE; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SPRAGUE DAWLEY RAT;

ADAPTOR PROTEIN COMPLEX 3; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE; ENDOCYTOSIS; FEMALE; GTPASE-ACTIVATING PROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M5; SEQUENCE ALIGNMENT;

MAMMALIA;

EID: 77955849103     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.154     Document Type: Article

References (78)

1. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, Seki K, Itohara S, Kawano M, Tanemura K, Takashima A, Yamada K, Kondoh Y, Kanno I, Wess J, Yamada M (2006) Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 24: 334-344
2. Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J (2002) Deletion of the M5 muscarinic acet-ylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci USA 99: 11452-11457
3. Bennett BD, Wilson CJ (1998) Synaptic regulation of action potential timing in neostriatal cholinergic interneurons. J Neurosci 18: 8539-8549
4. Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294: 1351-1362
5. Blumstein J, Faundez V, Nakatsu F, Saito T, Ohno H, Kelly RB (2001) The neuronal form of adaptor protein-3 is required for synaptic vesicle formation from endosomes. J Neurosci 21: 8034-8042
6. Bonifacino JS, Traub LM (2003) Signals for sorting of transmem-brane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447
7. D'Souza-Schorey C, Chavrier P (2006) ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7: 347-358
8. Dai J, Li J, Bos E, Porcionatto M, Premont RT, Bourgoin S, Peters PJ, Hsu VW (2004) ACAP1 promotes endocytic recycling by recognizing recycling sorting signals. Dev Cell 7: 771-776
9. De Luca V, Wang H, Squassina A, Wong GW, Yeomans J, Kennedy JL (2004) Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology 50: 124-127
10. Delaney KA, Murph MM, Brown LM, Radhakrishna H (2002) Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocy-tosis. J Biol Chem 277: 33439-33446
11. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS (1999) Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 3: 11-21
12. Di Pietro SM, Falcon-Perez JM, Tenza D, Setty SR, Marks MS, Raposo G, Dell'Angelica EC (2006) BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol Biol Cell 17: 4027-4038
13. Donaldson JG, Finazzi D, Klausner RD (1992) Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 360: 350-352
14. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256: 727-733
15. Flajolet M, Rotondo G, Daviet L, Bergametti F, Inchauspe G, Tiollais P, Transy C, Legrain P (2000) A genomic approach of the hepatitis C virus generates a protein interaction map. Gene 242: 369-379
16. Flajolet M, Wang Z, Futter M, Shen W, Nuangchamnong N, Bendor J, Wallach I, Nairn AC, Surmeier DJ, Greengard P (2008) FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat Neurosci 11: 1402-1409
17. Forster GL, Yeomans JS, Takeuchi J, Blaha CD (2002) M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22: RC190
18. Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, Daniele T, Marra P, Lucocq JM, De Matteis MA (2004) FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat Cell Biol 6: 393-404
19. Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78: 1-39
20. Hanyaloglu AC, von Zastrow M (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568
21. Kahn RA, Bruford E, Inoue H, Logsdon Jr JM, Nie Z, Premont RT, Randazzo PA, Satake M, Theibert AB, Zapp ML, Cassel D (2008) Consensus nomenclature for the human ArfGAP domain-containing proteins. J Cell Biol 182: 1039-1044
22. Kantheti P, Qiao X, Diaz ME, Peden AA, Meyer GE, Carskadon SL, Kapfhamer D, Sufalko D, Robinson MS, Noebels JL, Burmeister M (1998) Mutation in AP-3 delta in the mocha mouse links endo-somal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 21: 111-122
23. Lane PW, Deol MS (1974) Mocha, a new coat color and behavior mutation on chromosome 10 of the mouse. J Hered 65: 362-364
24. Lefrancois S, Janvier K, Boehm M, Ooi CE, Bonifacino JS (2004) An ear-core interaction regulates the recruitment of the AP-3 complex to membranes. Dev Cell 7: 619-625
25. Lemmon MA (2004) Pleckstrin homology domains: not just for phosphoinositides. Biochem Soc Trans 32 (Part 5): 707-711
26. Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, Tinsley CL, Blake DJ, Spritz RA, Copeland NG, Jenkins NA, Amato D, Roe BA, Starcevic M, Dell'Angelica EC, Elliott RW, Mishra V, Kingsmore SF, Paylor RE, Swank RT (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 35: 84-89
27. Lodowski DT, Pitcher JA, Capel WD, Lefkowitz RJ, Tesmer JJ (2003) Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Science 300: 1256-1262
28. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248: 1547-1550
29. Martire M, D'Amico M, Panza E, Miceli F, Viggiano D, Lavergata F, Iannotti FA, Barrese V, Preziosi P, Annunziato L, Taglialatela M (2007) Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. J Neurochem 102: 179-193
30. Meurer S, Pioch S, Wagner K, Muller-Esterl W, Gross S (2004) AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. J Biol Chem 279: 49346-49354
31. Miller AD, Blaha CD (2005) Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 21: 1837-1846
32. Moore CA, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69: 451-482
33. Morris SM, Cooper JA (2001) Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2: 111-123
34. Nakatsu F, Ohno H (2003) Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct 28: 419-429
35. Nakatsu F, Okada M, Mori F, Kumazawa N, Iwasa H, Zhu G, Kasagi Y, Kamiya H, Harada A, Nishimura K, Takeuchi A, Miyazaki T, Watanabe M, Yuasa S, Manabe T, Wakabayashi K, Kaneko S, Saito T, Ohno H (2004) Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol 167: 293-302
36. Newell-Litwa K, Chintala S, Jenkins S, Pare JF, McGaha L, Smith Y, Faundez V (2010) Hermansky-Pudlak protein complexes, AP-3 and BLOC-1, differentially regulate presynaptic composition in the striatum and hippocampus. J Neurosci 30: 820-831
37. Newell-Litwa K, Seong E, Burmeister M, Faundez V (2007) Neuronal and non-neuronal functions of the AP-3 sorting machinery. J Cell Sci 120 (Part 4): 531-541
38. Nie Z, Boehm M, Boja ES, Vass WC, Bonifacino JS, Fales HM, Randazzo PA (2003) Specific regulation of the adaptor protein complex AP-3 by the Arf GAP AGAP1. Dev Cell 5: 513-521
39. Nie Z, Fei J, Premont RT, Randazzo PA (2005) The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. J Cell Sci 11 8 (Part 15): 3555-3566
40. Nie Z, Randazzo PA (2006) Arf GAPs and membrane traffic. J Cell Sci 11 9 (Part 7): 1203-1211
41. Nie Z, Stanley KT, Stauffer S, Jacques KM, Hirsch DS, Takei J, Randazzo PA (2002) AGAP1, an endosome-associated, phosphoinositide-dependent ADP-ribosylation factor GTPase-activating protein that affects actin cytoskeleton. J Biol Chem 277: 48965-48975
42. Oki T, Takagi Y, Inagaki S, Taketo MM, Manabe T, Matsui M, Yamada S (2005) Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscari-nic acetylcholine receptor knockout mice. Brain Res Mol Brain Res 133: 6-11
43. Ooi CE, Dell'Angelica EC, Bonifacino JS (1998) ADP-Ribosylation factor 1 (ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J Cell Biol 142: 391-402
44. Peden AA, Oorschot V, Hesser BA, Austin CD, Scheller RH, Klumperman J (2004) Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins. J Cell Biol 164: 1065-1076
45. Pisani A, Bernardi G, Ding J, Surmeier DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30: 545-553
46. Popova JS, Rasenick MM (2004) Clathrin-mediated endocytosis of m3 muscarinic receptors. Roles for Gbetagamma and tubulin. J Biol Chem 279: 30410-30418
47. Premont RT, Gainetdinov RR (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69: 511-534
48. Ritter SL, Hall RA (2009) Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 10: 819-830
49. Salazar G, Craige B, Love R, Kalman D, Faundez V (2005) Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells. J Cell Sci 11 8 (Part 9): 1911-1921
50. Salazar G, Craige B, Styers ML, Newell-Litwa KA, Doucette MM, Wainer BH, Falcon-Perez JM, Dell'Angelica EC, Peden AA, Werner E, Faundez V (2006) BLOC-1 complex deficiency alters the targeting of adaptor protein complex-3 cargoes. Mol Biol Cell 17: 4014-4026
51. Salazar G, Love R, Werner E, Doucette MM, Cheng S, Levey A, Faundez V (2004) The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation. Mol Biol Cell 15: 575-587
52. Salazar G, Zlatic S, Craige B, Peden AA, Pohl J, Faundez V (2009) Hermansky-Pudlak syndrome protein complexes associate with phosphatidylinositol 4-kinase type II alpha in neuronal and non-neuronal cells. J Biol Chem 284: 1790-1802
53. Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D (2003) Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87: 273-289
54. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbin-din, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72: 185-190
55. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Peer I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757
56. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113: 1353-1363
57. Taneichi-Kuroda S, Taya S, Hikita T, Fujino Y, Kaibuchi K (2009) Direct interaction of Dysbindin with the AP-3 complex via its mu subunit. Neurochem Int 54: 431-438
58. Thomsen M, Woldbye DP, Wortwein G, Fink-Jensen A, Wess J, Caine SB (2005) Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci 25: 8141-8149
59. Tolbert LM, Lameh J (1996) Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles. J Biol Chem 271: 17335-17342
60. Volpicelli LA, Lah JJ, Levey AI (2001) Rab5-dependent trafficking of the m4 muscarinic acetylcholine receptor to the plasma membrane, early endosomes, and multivesicular bodies. J Biol Chem 276: 47590-47598
61. Wang H, Ng K, Hayes D, Gao X, Forster G, Blaha C, Yeomans J (2004) Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region. Neuropsychopharmacology 29: 2126-2139
62. Weiner DM, Levey AI, Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87: 7050-7054
63. Wess J, Blin N, Mutschler E, Bluml K (1995) Muscarinic acetylcho-line receptors: structural basis of ligand binding and G protein coupling. Life Sci 56: 915-922
64. Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6: 721-733
65. Westphalen RI, Hemmings Jr HC (2003) Selective depression by general anesthetics of glutamate versus GABA release from solated cortical nerve terminals. J Pharmacol Exp Ther 304: 1188-1196
66. Xia C, Ma W, Stafford LJ, Liu C, Gong L, Martin JF, Liu M (2003) GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. Mol Cell Biol 23: 2476-2488
67. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J (2001) Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 98: 14096-14101
68. Yan Z, Surmeier DJ (1996) Muscarinic (m2/m4) receptors reduce N-and P-type Ca2+ currents in rat neostriatal cholinergic inter-neurons through a fast, membrane-delimited, G-protein pathway. J Neurosci 16: 2592-2604
69. Yap CC, Wisco D, Kujala P, Lasiecka ZM, Cannon JT, Chang MC, Hirling H, Klumperman J, Winckler B (2008) The somatodendri-tic endosomal regulator NEEP21 facilitates axonal targeting of L1/NgCAM. J Cell Biol 180: 827-842
70. Yeomans J, Forster G, Blaha C (2001) M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68: 2449-2456
71. Zhang H, Craciun LC, Mirshahi T, Rohacs T, Lopes CM, Jin T, Logothetis DE (2003) PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37: 963-975
72. Zhang H, Sulzer D (2003) Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci 23: 10585-10592
73. Zhang H, Sulzer D (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7: 581-582
74. Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J (2002a) Characterization of central inhibitory muscarinic auto-receptors by the use of muscarinic acetylcholine receptor knockout mice. J Neurosci 22: 1709-1717
75. Zhang W, Yamada M, Gomeza J, Basile AS, Wess J (2002b) Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 22: 6347-6352
76. Zhou FM, Liang Y, Dani JA (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4: 1224-1229
77. Zhou FM, Wilson CJ, Dani JA (2002) Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53: 590-605
78. Zhou M, Rebholz H, Brocia C, Warner-Schmidt JL, Fienberg AA, Nairn AC, Greengard P, Flajolet M (2010) Forebrain overexpres-sion of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Natl Acad Sci USA 107: 4401-4406